Rhovac hires investment bank to generate interest in lead candidate
![Photo: Jens Dresling](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13357722.ece/ALTERNATES/schema-16_9/doc7hx2wl8lqljtmkc2m3r.jpg)
Danish biotech company Rhovac, spearheaded by Anders Månsson, former executive of Leo Pharma and Ferring Pharmaceuticals, has made it its goal to examine the opportunities of either striking a deal or entering a partnership pertaining to its lead candidate RV001, the company reports in a press relase on Monday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
IO Biotech begins phase III trial with partner MSD
For subscribers
Sanofi pays up to USD 1bn for new multiple myeloma therapy
For subscribers